CERo Therapeutics Holdings, Inc.
CERO
$0.09
$0.0113.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 500.00K | -- | -- | -- | -- |
| Gross Profit | -500.00K | -- | -- | -- | -- |
| SG&A Expenses | 1.98M | 2.68M | 2.20M | 2.79M | 2.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.86M | 5.43M | 5.11M | 2.10M | 4.40M |
| Operating Income | -4.86M | -5.43M | -5.11M | -2.10M | -4.40M |
| Income Before Tax | -4.86M | -5.42M | -5.11M | 671.90K | -4.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.86M | -5.42M | -5.11M | 671.90K | -4.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.86M | -5.42M | -5.11M | 671.90K | -4.23M |
| EBIT | -4.86M | -5.43M | -5.11M | -2.10M | -4.40M |
| EBITDA | -4.79M | -5.36M | -5.03M | -2.00M | -4.29M |
| EPS Basic | -9.10 | -61.71 | -33.42 | -35.71 | -170.22 |
| Normalized Basic EPS | -2.40 | -6.94 | -19.55 | -28.17 | -106.39 |
| EPS Diluted | -9.10 | -61.71 | -33.42 | -35.71 | -170.22 |
| Normalized Diluted EPS | -2.40 | -6.94 | -19.55 | -28.17 | -106.39 |
| Average Basic Shares Outstanding | 1.26M | 488.10K | 3.60M | 1.30M | 24.80K |
| Average Diluted Shares Outstanding | 1.26M | 488.10K | 3.60M | 1.30M | 24.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |